Complement binding aptamers and anti-C5 agents useful in the treatment of ocular disorders

Details for Australian Patent Application No. 2007223796 (hide)

Owner Archemix Corp.

Inventors Epstein, David; Kurz, Jeff C.

Agent Cullen & Co

Pub. Number AU-A-2007223796

PCT Pub. Number WO2007/103549

Priority 60/848,274 29.09.06 US; 60/780,905 08.03.06 US

Filing date 8 March 2007

Wipo publication date 13 September 2007

International Classifications

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

Event Publications

25 September 2008 PCT application entered the National Phase

  PCT publication WO2007/103549 Priority application(s): WO2007/103549

16 February 2012 Alteration of Name

  The name of the applicant has been altered to Archemix LLC

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007223797-Substituted aminothiazole derivatives with anti-HCV activity

2007223788-Diagnostic and prognostic methods for lung disorders using gene expression profiles from nose epithelial cells